Close

Spectrum Pharmaceuticals, Inc. (SPPI) Tops Q2 EPS by 18c

August 7, 2014 4:49 PM EDT

Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) reported Q2 EPS of $0.09, $0.18 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $46.9 million versus the consensus estimate of $41.5 million.

For earnings history and earnings-related data on Spectrum Pharmaceuticals, Inc. (SPPI) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings